Sino Medical Sciences Technology Inc. (SHA:688108)
China
· Delayed Price · Currency is CNY 10.61
+0.74 (7.50%)
May 27, 2025, 2:45 PM CST
SHA:688108 Revenue
Sino Medical Sciences Technology had revenue of 100.85M CNY in the quarter ending March 31, 2025, with 10.75% growth. This brings the company's revenue in the last twelve months to 468.53M, up 29.73% year-over-year. In the year 2024, Sino Medical Sciences Technology had annual revenue of 458.74M with 33.64% growth.
Revenue (ttm)
468.53M
Revenue Growth
+29.73%
P/S Ratio
9.44
Revenue / Employee
718.60K
Employees
652
Market Cap
4.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 458.74M | 115.48M | 33.64% |
| Dec 31, 2023 | 343.26M | 150.40M | 77.99% |
| Dec 31, 2022 | 192.85M | -1.50M | -0.77% |
| Dec 31, 2021 | 194.36M | -133.06M | -40.64% |
| Dec 31, 2020 | 327.42M | -108.49M | -24.89% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |